Background: The aim of this paper is to discuss the impact of COVID-19 on patients with
urological malignancies (prostate cancer, bladder and upper tract urothelial cancer, kidney …

Purpose To summarize the available evidence on the survival and pathologic outcomes
after deferred radical prostatectomy (RP) in men with intermediate-and high-risk prostate …

Introduction Our study aims to evaluate the impact of the COVID-19 pandemic on the
number of uro-oncological surgeries (cystectomy, nephrectomy, prostatectomy, orchiectomy …

PURPOSE This study examined changes in prostate disease screening (prostatic-specific
antigen [PSA] testing), prostate biopsy testing, and prostate cancer diagnoses during the …

The COVID‐19 pandemic led to a major disruption to health services across the world. The
aim of this population‐based study was to assess the downstream effects of the pandemic …

Background: Healthcare across all sectors, in the UK and globally, was negatively affected
by the COVID-19 pandemic. We analysed healthcare services delivered to people with …

Background: Internationally, Mobile Stroke Unit (MSU) ambulances have changed pre-
hospital acute stroke care delivery. MSU clinical and cost-effectiveness studies are …

Purpose: Prostate cancer is most commonly an indolent disease, especially when detected
at a localized stage. Unlike other tumors that may benefit from timely receipt of definitive …

We aimed to assess whether the ongoing course of the COVID-19 epidemic has been
associated with an increased risk of adverse pathology (AP) findings in prostate cancer (PC) …

Purpose To assess differences in referral and pathologic outcomes for uro-oncology cases
prior to and during the COVID pandemic, comparing clinical and pathological data of cancer …